+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Helicobacter Pylori Diagnostics Market - Global Forecast 2026-2032- Product Image
Helicobacter Pylori Diagnostics Market - Global Forecast 2026-2032- Product Image
Sale

Helicobacter Pylori Diagnostics Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5639880
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Helicobacter Pylori Diagnostics Market is projected to reach USD 969.47 Million in 2026. It is expected to continue growing at a CAGR of 7.34%, reaching USD 1.48 Billion by 2032.

Helicobacter pylori diagnostics are central to the prevention, diagnosis, and management of gastritis, peptic ulcer disease, gastric mucosa-associated lymphoid tissue lymphoma, and gastric cancer risk. The organism is classified by the International Agency for Research on Cancer as a Group 1 carcinogen, making accurate detection, eradication confirmation, and resistance-aware care a public health priority.

Demand is supported by guideline-based use of noninvasive urea breath tests, stool antigen tests, serology in selected settings, endoscopic biopsy-based histology, rapid urease testing, culture, and molecular assays. Momentum is strongest where clinicians are shifting from one-time detection toward test-and-treat pathways, post-treatment eradication confirmation, and antimicrobial resistance surveillance.

Transformative Shifts in the H. Pylori Testing Landscape

The landscape is moving from empiric, symptom-led testing to evidence-based pathways that align diagnostics with eradication therapy. Current clinical guidance increasingly emphasizes confirmation of active infection and test-of-cure after treatment, supporting higher use of urea breath and stool antigen testing over antibody-only approaches when active infection status is required.

A second structural shift is the rise of molecular testing for clarithromycin and other resistance markers. As H. pylori antibiotic resistance has increased globally, laboratories, gastroenterology practices, and public health systems are prioritizing diagnostics that can improve treatment selection, reduce repeat therapy, and support antimicrobial stewardship. This transition is also increasing the importance of validated sample handling, assay standardization, and clinically interpretable reporting.

Cumulative Impact of Artificial Intelligence on H. Pylori Diagnostics

Artificial intelligence is adding cumulative value across the H. pylori diagnostics workflow rather than replacing validated assays. In endoscopy, AI-enabled image analysis is being studied to support detection of gastritis patterns associated with infection, while digital pathology tools can assist review of biopsy slides and standardize interpretation where specialist capacity is constrained.

AI also strengthens operational performance. Predictive analytics can identify higher-risk populations for targeted testing, automate quality checks in laboratories, and improve planning for diagnostic kit utilization. The strongest near-term impact is expected where AI is paired with regulated tests, electronic health records, endoscopy data, pathology images, and antimicrobial resistance information to guide clinically actionable decisions.

Key Regional Insights Across Major H. Pylori Diagnostics Markets

Asia-Pacific carries a high clinical burden because many countries combine large populations, variable sanitation history, and substantial gastric cancer prevention needs; this supports broad use of noninvasive testing and endoscopy-linked diagnosis. North America is characterized by guideline-driven testing, strong reimbursement scrutiny, established laboratory networks, and increasing attention to post-treatment confirmation, while Latin America shows rising demand as access to gastroenterology, private laboratories, and hospital-based diagnostic infrastructure expands.

In Europe, organized clinical pathways, antimicrobial stewardship, and resistance-aware management support adoption of validated breath, stool, histology, and molecular tests. The Middle East is shaped by investment in tertiary care, medical tourism, and higher testing access in urban centers, especially where specialist gastroenterology services are concentrated. Africa remains heterogeneous, with major opportunities in affordable stool antigen testing, decentralized diagnostics, public health education, and capacity building for endoscopy, pathology, and laboratory quality systems.

Key Group Insights for ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, demand is linked to urban healthcare expansion, private diagnostics growth, improving endoscopy access, and gastric disease awareness, while the GCC benefits from modern hospital networks, high healthcare investment, and increasing use of advanced diagnostic platforms in specialty care. The European Union is guided by harmonized quality expectations, regulated in vitro diagnostic pathways, antimicrobial stewardship, and clinical preference for accurate active-infection testing.

Across BRICS, large patient pools and uneven access create parallel demand for low-cost, high-volume tests and advanced molecular solutions that support resistance-aware treatment. G7 countries lead in guideline adoption, quality management, digital health integration, and test-of-cure compliance. NATO members overlap with many advanced economies where supply security, laboratory resilience, regulated procurement, and continuity of essential diagnostics are increasingly strategic healthcare considerations.

Key Country Insights for Priority H. Pylori Diagnostics Markets

The United States and Canada show strong use of guideline-based noninvasive testing, with emphasis on eradication confirmation, appropriate test selection, and avoidance of serology when active infection status is needed. Mexico and Brazil present expanding opportunities as private laboratories, hospital networks, and gastric disease awareness grow. In Europe, the United Kingdom, Germany, France, Italy, and Spain support demand through established gastroenterology services, laboratory accreditation, and stewardship-focused care pathways, while Russia combines large geographic need with variable regional access to specialist diagnostics.

In Asia-Pacific, China, India, and Japan are pivotal because of large populations, high gastric disease relevance, and growing investment in diagnostics; Japan also has longstanding gastric cancer prevention practices that support structured H. pylori management and eradication confirmation. Australia maintains high standards for validated testing and evidence-based reimbursement decisions, and South Korea benefits from advanced endoscopy capacity, strong hospital infrastructure, and national attention to gastric cancer screening.

Actionable Recommendations for H. Pylori Diagnostics Leaders

Industry leaders should prioritize assays that detect active infection, support test-of-cure, and fit local clinical workflows. Urea breath and stool antigen platforms should be positioned around accuracy, patient convenience, pre-analytical reliability, and compliance with guideline-based care, while molecular tests should emphasize resistance detection and treatment optimization.

Commercial strategies should combine clinician education, payer evidence, laboratory partnerships, and region-specific affordability models. Leaders should document analytical and clinical performance, reduce turnaround time, ensure supply continuity, support quality-control programs, and integrate results into digital care pathways. Differentiation will increasingly depend on usability, resistance-aware reporting, regulatory readiness, and the ability to improve eradication outcomes without adding workflow complexity.

Research Methodology for the H. Pylori Diagnostics Analysis

The research approach integrates secondary analysis of clinical guidelines, regulatory frameworks, peer-reviewed literature, public health references, antimicrobial resistance reports, and in vitro diagnostics industry disclosures. Sources are evaluated for relevance to H. pylori detection, active-infection confirmation, post-treatment testing, resistance surveillance, test performance, and regional access conditions.

Market interpretation is supported by triangulation across test modality adoption, healthcare infrastructure, reimbursement practices, disease burden indicators, laboratory capacity, endoscopy availability, and expert-informed assessment of diagnostic workflows. Findings are validated for consistency with established gastroenterology, oncology prevention, infectious disease, and laboratory medicine standards rather than unsupported market-size or forecasting claims.

Conclusion: Strategic Outlook for Helicobacter Pylori Diagnostics

The Helicobacter pylori diagnostics landscape is evolving from basic infection identification toward precision-oriented management that confirms active disease, verifies eradication, and addresses antibiotic resistance. This shift strengthens the role of high-quality noninvasive tests, molecular assays, endoscopy-linked diagnostics, and integrated laboratory services.

Organizations that align product development with clinical guidelines, regional affordability, AI-enabled workflow improvement, laboratory quality standards, and antimicrobial stewardship will be well positioned to support sustainable growth while improving outcomes in gastric disease prevention and treatment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Helicobacter Pylori Diagnostics Market, by Test Type
7.1. Introduction
7.2. Non-Invasive Tests
7.2.1. Urea Breath Test
7.2.2. Stool Antigen Test
7.2.3. Serology Test
7.3. Invasive Tests
7.3.1. Endoscopy-Based Diagnosis
7.3.2. Biopsy-Based Tests
7.3.2.1. Rapid Urease Test
7.3.2.2. Histology
7.3.2.3. Culture Test
7.3.2.4. Molecular Tests (PCR)
8. Helicobacter Pylori Diagnostics Market, by Product Type
8.1. Introduction
8.2. Consumables
8.2.1. Kits
8.2.2. Reagents
8.2.3. Test Strips
8.3. Instruments
8.3.1. Breath Test Analyzers
8.3.2. Endoscopy Equipment
8.3.3. PCR Systems
9. Helicobacter Pylori Diagnostics Market, by Technology
9.1. Introduction
9.2. Immunoassay-Based Diagnostics
9.2.1. ELISA Tests
9.2.2. Rapid Test Kits
9.3. Molecular Diagnostics
9.4. Breath Analysis Technology
9.5. Microbiological Culture Methods
9.6. Histopathology Techniques
10. Helicobacter Pylori Diagnostics Market, by Age Group
10.1. Introduction
10.2. Pediatric
10.3. Adult
10.4. Geriatric
11. Helicobacter Pylori Diagnostics Market, by End User
11.1. Introduction
11.2. Ambulatory Care Centers
11.3. Clinics
11.4. Diagnostic Laboratories
11.5. Hospitals
12. Helicobacter Pylori Diagnostics Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Helicobacter Pylori Diagnostics Market, by Group
13.1. NATO
13.2. G7
13.3. European Union
13.4. BRICS
13.5. ASEAN
13.6. GCC
14. Helicobacter Pylori Diagnostics Market, by Country
14.1. United States
14.2. China
14.3. Germany
14.4. Japan
14.5. India
14.6. United Kingdom
14.7. France
14.8. Australia
14.9. Italy
14.10. Canada
14.11. South Korea
14.12. Brazil
14.13. Russia
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Thermo Fisher Scientific Inc.
16.2. Abbott Laboratories
16.3. F. Hoffmann-La Roche Ltd
16.4. Bio-Rad Laboratories, Inc.
16.5. Quest Diagnostics Incorporated
16.6. bioMérieux SA
16.7. DiaSorin S.p.A.
16.8. Meridian Bioscience, Inc.
16.9. Alere Inc.
16.10. Alpha Laboratories Ltd.
16.11. Becton, Dickinson and Company
16.12. Cardinal Health, Inc.
16.13. Certest Biotec S.L.
16.14. Coris BioConcept
16.15. Diagnostic BioSystems, Inc
16.16. EKF Diagnostics Holdings plc
16.17. Epitope Diagnostics, Inc.
16.18. Exalenz Bioscience Ltd.
16.19. Halyard Health, Inc.
16.20. Medix Biochemica Oy
16.21. Medline Industries, Inc.
16.22. MP Biomedicals, LLC
16.23. QuidelOrtho Corporation
16.24. Savyon Diagnostics Ltd.
16.25. Sekisui Diagnostics LLC
List of Figures
FIGURE 1. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 13. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL NON-INVASIVE TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL NON-INVASIVE TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL NON-INVASIVE TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL UREA BREATH TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL UREA BREATH TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL UREA BREATH TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL STOOL ANTIGEN TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL STOOL ANTIGEN TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL STOOL ANTIGEN TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SEROLOGY TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SEROLOGY TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SEROLOGY TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL INVASIVE TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL INVASIVE TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL INVASIVE TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ENDOSCOPY-BASED DIAGNOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL ENDOSCOPY-BASED DIAGNOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL ENDOSCOPY-BASED DIAGNOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL BIOPSY-BASED TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL BIOPSY-BASED TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL BIOPSY-BASED TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL RAPID UREASE TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL RAPID UREASE TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL RAPID UREASE TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL HISTOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL HISTOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL HISTOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CULTURE TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CULTURE TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL CULTURE TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL MOLECULAR TESTS (PCR) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL MOLECULAR TESTS (PCR) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL MOLECULAR TESTS (PCR) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL TEST STRIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL TEST STRIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL TEST STRIPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BREATH TEST ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BREATH TEST ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL BREATH TEST ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ENDOSCOPY EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ENDOSCOPY EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ENDOSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PCR SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PCR SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PCR SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL IMMUNOASSAY-BASED DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL IMMUNOASSAY-BASED DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL IMMUNOASSAY-BASED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ELISA TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ELISA TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ELISA TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL RAPID TEST KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL RAPID TEST KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL RAPID TEST KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL BREATH ANALYSIS TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL BREATH ANALYSIS TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL BREATH ANALYSIS TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL MICROBIOLOGICAL CULTURE METHODS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL MICROBIOLOGICAL CULTURE METHODS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL MICROBIOLOGICAL CULTURE METHODS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL HISTOPATHOLOGY TECHNIQUES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL HISTOPATHOLOGY TECHNIQUES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL HISTOPATHOLOGY TECHNIQUES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 120. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 122. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 123. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 124. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 125. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 126. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 127. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 128. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 129. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 130. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 131. EUROPE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 141. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 155. LATIN AMERICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 157. AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 158. AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 159. AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 160. AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 161. AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 162. AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 163. AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 164. AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 165. AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 166. AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 167. AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 180. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 181. NATO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. NATO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 183. NATO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 184. NATO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 185. NATO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 186. NATO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 187. NATO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 188. NATO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 189. NATO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 190. NATO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 191. NATO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 192. NATO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 193. G7 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. G7 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 195. G7 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 196. G7 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 197. G7 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 198. G7 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 199. G7 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 200. G7 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 201. G7 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 202. G7 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 203. G7 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 204. G7 HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 217. BRICS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 218. BRICS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 219. BRICS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 220. BRICS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 221. BRICS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 222. BRICS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 223. BRICS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 224. BRICS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 225. BRICS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 226. BRICS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 227. BRICS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 228. BRICS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 229. ASEAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 230. ASEAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 231. ASEAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 232. ASEAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 233. ASEAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 234. ASEAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 235. ASEAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 236. ASEAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 237. ASEAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 238. ASEAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 239. ASEAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 240. ASEAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 241. GCC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 242. GCC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 243. GCC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 244. GCC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 245. GCC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 246. GCC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 247. GCC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 248. GCC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 249. GCC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 250. GCC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 251. GCC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 252. GCC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 253. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 254. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 256. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 257. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 258. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 259. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 260. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 261. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 262. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 263. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 264. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 265. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 267. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 268. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 269. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 270. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 271. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 272. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 273. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 274. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 275. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 276. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 277. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 280. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 281. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 282. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 283. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 284. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 285. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 286. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 287. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 288. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 289. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 290. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 292. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 293. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 294. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 295. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 296. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 297. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 298. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 299. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 300. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 301. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 302. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 304. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 305. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 306. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 307. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 308. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 309. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 310. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 311. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 312. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 313. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 314. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 316. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 317. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 320. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 321. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 322. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 323. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY-BASED DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 324. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 325. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 326. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 328. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 329. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY INVASIVE TESTS, 2017-2032 (USD MILLION)
TABLE 330. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY BIOPSY-BASED TESTS, 2017-2032 (USD MILLION)
TABLE 331. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 332. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 201

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Quest Diagnostics Incorporated
  • bioMérieux SA
  • DiaSorin S.p.A.
  • Meridian Bioscience, Inc.
  • Alere Inc.
  • Alpha Laboratories Ltd.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Certest Biotec S.L.
  • Coris BioConcept
  • Diagnostic BioSystems, Inc
  • EKF Diagnostics Holdings plc
  • Epitope Diagnostics, Inc.
  • Exalenz Bioscience Ltd.
  • Halyard Health, Inc.
  • Medix Biochemica Oy
  • Medline Industries, Inc.
  • MP Biomedicals, LLC
  • QuidelOrtho Corporation
  • Savyon Diagnostics Ltd.
  • Sekisui Diagnostics LLC

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 969.47 Million
Forecasted Market Value ( USD ) by 2032 $ 1480 Million
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Helicobacter Pylori Non-invasive Testing Market - Global Forecast 2026-2032 - Product Image

Helicobacter Pylori Non-invasive Testing Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Helicobacter Pylori Diagnostics - Global Strategic Business Report - Product Image

Helicobacter Pylori Diagnostics - Global Strategic Business Report

  • Report
  • 249 Pages
  • Global
From
Helicobacter Pylori Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Helicobacter Pylori Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 181 Pages
  • Global
From
Non-invasive Helicobacter Pylori Testing - Global Strategic Business Report - Product Image

Non-invasive Helicobacter Pylori Testing - Global Strategic Business Report

  • Report
  • 176 Pages
  • Global
From
Helicobacter Pylori Testing Market Outlook 2026-2034: Market Share, and Growth Analysis by Test Type, End-User, Technology - Product Image

Helicobacter Pylori Testing Market Outlook 2026-2034: Market Share, and Growth Analysis by Test Type, End-User, Technology

  • Report
  • 160 Pages
  • Global
From

About the Market

The Helicobacter Pylori Test is a diagnostic test used to detect the presence of the Helicobacter pylori bacteria in the stomach. This bacteria is associated with a number of gastrointestinal diseases, including gastritis, peptic ulcer disease, and gastric cancer. The test is used to diagnose and monitor the effectiveness of treatment for these conditions. The test is typically performed using a blood sample, stool sample, or breath test. The Helicobacter Pylori Test market is a subset of the larger Infectious Disease Testing market. This market is driven by the increasing prevalence of infectious diseases, the need for accurate and timely diagnosis, and the development of new technologies. Some companies in the Helicobacter Pylori Test market include Abbott Laboratories, Becton Dickinson, Cepheid, DiaSorin, and Hologic. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.